A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)
Recruiting
Phase 1
Interventional Study
Healthy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 55
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 60 (estimated)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This goal of this trial is to learn about two medicines, enlicitide and rosuvastatin, in healthy people. Researchers will compare the amounts of enlicitide and rosuvastatin in a person's body over time, when they are given as separate medicines and when they are combined into one tablet.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
The main inclusion criteria include but are not limited to the following:
* Is medically healthy with no clinically significant medical history
* Is a non-smoker who has not used nicotine- and tobacco-containing products for at least 3 months prior to study entry
Exclusion Criteria:
* Is unable t…
Contacts